Let’s explore lymphoma, a type of blood cancer that affects the lymphatic system, which presents itself in two primary forms: Hodgkin lymphoma and non-Hodgkin lymphoma. While both types begin with lymphocytes, they each have their own distinct characteristics. Join us as we unravel the differences between these two types of lymphoma, aiming to provide clarity and understanding to each one. Understanding the nuances between Hodgkin and non-Hodgkin lymphoma can help us better support those navigating their diagnosis.
Hodgkin lymphoma is a distinct form of blood cancer with unique characteristics. One notable characteristic is the presence of Reed-Sternberg cells, which are large abnormal cells found in affected lymph nodes. Understanding the significance of these cells plays a key role in diagnosing and classifying this type of cancer.
Unlike Hodgkin lymphoma, non-Hodgkin lymphoma is a type of cancer that’s diverse, encompassing over 60 different subtypes. Each subtype has its own distinct features that influence both prognosis and treatment approaches. Understanding these differences is key to navigating the complexities of non-Hodgkin lymphoma.
While both Hodgkin and non-Hodgkin lymphomas share the commonality of impacting the lymphatic system, they each have unique characteristics that distinguish them from one another.
One notable difference lies in in the cells affected: Hodgkin lymphoma usually starts from a specific type of abnormal B-cells known as Reed-Sternberg cells while non-Hodgkin arises from various types of white blood cells, such as B-cells, T-cells, or natural killer cells.
Another important contrast is their relative prevalence; non-Hodgkin lymphoma is more commonly diagnosed than Hodgkin, accounting for around 90% of all cases of lymphoma.
Additionally, it’s worth mentioning that while both types of lymphoma can occur at any age, Hodgkin tends to peak in early adulthood and late adulthood whereas non-Hodgkins’ is typically diagnosed in individuals over the age of 60.
When it comes to diagnosing and treating Hodgkin lymphoma and non-Hodgkin lymphoma, medical assessments play a key role. These assessments, which include biopsies, imaging tests, and blood work, help determine the type of cancer, its stage, and prognosis. For Hodgkin lymphoma, the main treatments include targeted therapies such as chemotherapy and radiation therapy to effectively combat the abnormal cells.
Treating non-Hodgkin lymphoma, on the other hand, requires a more diverse approach due to its various subtypes and potential aggressiveness. One notable development in treatment research involves immunotherapy, a method that explores harnessing the body’s immune system to target and eliminate cancerous cells in certain forms of non-Hodgkin lymphoma. It’s a ray of hope in the journey towards effective treatment.
These advancements in treatment offer hope and possibilities for those navigating their lymphoma diagnosis.
Understanding the differences between Hodgkin lymphoma and non-Hodgkin lymphoma paves the way for accurately diagnosing and planning effective treatments.
At the Follicular Lymphoma Foundation, we’re deeply committed to propelling the journey towards finding a cure for follicular lymphoma. Through our unwavering dedication to research and treatment, we’re at the forefront of follicular lymphoma research and advocacy, driven by the incredible support of our community.
There are plenty of ways to lend a hand to the Follicular Lymphoma Foundation in our mission. Whether it’s through donations, participating in our fundraising efforts, or actively engaging with the FLF community, every bit of help makes a meaningful impact on advancing follicular lymphoma research and improving the lives of patients.
Disclaimer: The information provided in this blog post is for educational purposes only and should not be considered a substitute for professional medical advice. Always consult with your healthcare provider for personalised guidance and treatment options.
